Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CGC Genetics is a Portugal-based medical genetics and genomics diagnostics company that operates as part of Unilabs. Founded in 1992, it built its reputation as one of Portugal's leading private medical genetics laboratories and offers a broad menu of more than 3,800 to 4,000 genetic tests spanning clinical genomics, molecular diagnostics, cytogenetics, prenatal screening, and pathology. The company serves hospitals, clinics, insurers, universities, academic researchers, and biopharma customers, and also supports clinical trials, sponsored testing, biomarker discovery, and patient identification programs. Its operations are centered on advanced laboratory workflows in Porto supported by AI tools and bioinformatics platforms for interpretation of rare disease, oncology, and other hereditary conditions. CGC Genetics is not a drug developer; it is a commercial diagnostics and laboratory services business focused on genetic testing and genomic insight generation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CGC Genetics.